MetLife Investment Management, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 55 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$621,795
+39.0%
27,1230.0%0.01%
+66.7%
Q2 2023$447,258
+58.8%
27,123
+11.0%
0.00%
+50.0%
Q1 2022$281,572
+83.5%
24,442
+59.0%
0.00%
+100.0%
Q4 2021$153,413
-23.6%
15,3720.0%0.00%
-50.0%
Q3 2021$200,758
-33.3%
15,3720.0%0.00%
-33.3%
Q2 2021$300,984
-7.9%
15,3720.0%0.00%0.0%
Q1 2021$326,962
-28.5%
15,3720.0%0.00%
-40.0%
Q4 2020$457,010
+37.2%
15,3720.0%0.01%
+25.0%
Q3 2020$333,111
-2.8%
15,3720.0%0.00%0.0%
Q2 2020$342,796
+67.3%
15,372
+14.2%
0.00%
+33.3%
Q1 2020$204,937
-33.7%
13,4650.0%0.00%0.0%
Q4 2019$309,156
+27.2%
13,465
+19.6%
0.00%0.0%
Q3 2019$243,017
-1.9%
11,2560.0%0.00%0.0%
Q2 2019$247,630
+45.9%
11,256
+81.8%
0.00%
+50.0%
Q1 2019$169,723
+2.0%
6,1920.0%0.00%0.0%
Q4 2018$166,441
-7.9%
6,1920.0%0.00%0.0%
Q3 2018$180,621
-37.1%
6,192
-37.2%
0.00%
-33.3%
Q4 2017$287,0009,8620.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,075,000$47,569,3755.56%
NEA Management Company, LLC 2,909,956$66,710,7415.15%
Opaleye Management Inc. 653,000$14,970,0254.87%
Frazier Life Sciences Management, L.P. 2,371,304$54,362,1443.61%
VR Adviser, LLC 1,090,000$24,988,2502.63%
RA Capital Management 5,676,067$130,123,8362.56%
Samsara BioCapital, LLC 345,293$7,915,8422.42%
SILVERARC CAPITAL MANAGEMENT, LLC 260,537$5,972,8111.81%
Logos Global Management LP 400,000$9,170,0001.22%
Cormorant Asset Management, LP 850,000$19,486,2501.14%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders